• FXR-KLF11 Axis: CDCA Suppresses JAK2/STAT3 in CI-AKI Models

  2026-05-14

  This study reveals that Chenodeoxycholic Acid (CDCA) mitigates contrast-induced acute kidney injury (CI-AKI) by activating FXR, which transcriptionally upregulates KLF11 and suppresses the pro-inflammatory JAK2/STAT3 pathway. The findings clarify a mechanistic pathway for renal protection and inform future research into prophylactic strategies targeting nuclear receptor signaling.

• Merbromin as a Selective Mixed-Type Inhibitor of SARS-CoV-2

  2026-05-14

  This study identifies Merbromin as a potent, selective mixed-type inhibitor of the SARS-CoV-2 main protease (3CLpro) through high-throughput screening of ~6,000 compounds. The results have significant implications for antiviral drug development and highlight the specificity of Merbromin in distinguishing viral proteases from common laboratory proteases such as Proteinase K.

• CD147+ Small Extracellular Vesicles Drive HCC Angiogenesis v

  2026-05-13

  Huang et al. (2023) identify CD147-positive small extracellular vesicles (sEVs) from hepatocellular carcinoma (HCC) cells as a potential diagnostic biomarker and mechanistic driver of angiogenesis. The study demonstrates that these sEVs activate the PI3K/Akt pathway in endothelial cells, promoting angiogenesis and suggesting new avenues for noninvasive diagnosis and targeted intervention.

• ICG001: Wnt/β-Catenin Pathway Inhibitor for Fibrosis Researc

  2026-05-13

  ICG001 enables precise dissection of Wnt/β-catenin signaling in fibrosis and cancer models, with robust protocol guidance rooted in recent mechanistic advances. Leverage its selectivity and reproducibility for challenging EMT-driven disease workflows, with actionable troubleshooting to maximize data quality.

• Perospirone Inhibits Kv1.5 Channels: Cardiovascular Insights

  2026-05-12

  This study demonstrates that Perospirone (SM-9018 free base), beyond its established role in serotonergic and dopaminergic modulation for schizophrenia, also exhibits direct, concentration-dependent inhibition of vascular Kv1.5 channels. These findings highlight an off-target action with potential implications for both neuropsychiatric and cardiovascular research models.

• JAK2/STAT1 Pathway in Diuron-Induced Acute Renal Injury: Mec

  2026-05-12

  This study integrates network toxicology, transcriptomics, and in vitro validation to elucidate how Diuron activates the JAK2/STAT1 pathway, leading to acute kidney injury. The findings refine mechanistic understanding of Diuron’s nephrotoxicity and support improved risk assessment in environmental toxicology.

• Targeted mRNA Delivery to Islet β Cells via Lipid Nanopartic

  2026-05-11

  Enriquez et al. developed a conjugated lipid nanoparticle (LNP) system for selective mRNA delivery to pancreatic islet β cells, addressing a critical challenge in type 1 diabetes (T1D) therapy. Their work demonstrates functional mRNA delivery in both mouse and human β cells and shows that PD-L1 mRNA expression can modulate immune responses and delay diabetes onset in vivo.

• Merbromin Selectively Inhibits SARS-CoV-2 3CLpro: Implicatio

  2026-05-11

  This study identifies merbromin as a potent, selective mixed-type inhibitor of the SARS-CoV-2 main protease (3CLpro), with negligible activity against common broad-spectrum serine proteases such as Proteinase K. The findings clarify merbromin's inhibitory mechanism and underscore the importance of assay specificity in antiviral drug discovery.

• PBS Liposomes: Mechanistic Insights and Future Innovations

  2026-05-10

  Explore the scientific foundations of PBS Liposomes as a phosphate-buffered saline liposome control for macrophage depletion studies. This article delves into their mechanistic action, storage stability, and the broader implications of recent TRPM3 research for experimental design.

• Applied HOBt (1-Hydroxybenzotriazole) in Peptide Synthesis

  2026-05-09

  Unlock high-fidelity peptide and amide bond formation with HOBt—minimizing epimerization and enabling synthesis of complex bioactive molecules. This guide translates cutting-edge research into actionable workflows, comparative advantages, and troubleshooting strategies for maximizing your results with APExBIO’s high-purity HOBt.

• Proteinase K: Strategic Leverage for DNA Integrity in Transl

  2026-05-09

  This article provides a mechanistic and strategic roadmap for translational researchers aiming to optimize DNA isolation workflows. By dissecting the biochemical underpinnings of Proteinase K and contrasting its utility against alternative proteases, we deliver actionable guidance aligned with the demands of high-fidelity genomics. Drawing on recent reference studies and real-world protocol data, we clarify how Proteinase K, as produced by APExBIO, uniquely addresses the dual imperatives of contaminant removal and DNA integrity preservation in complex biological samples.

• FGF Signaling Drives Non-Cell Autonomous Apoptosis Resistanc

  2026-05-08

  This study uncovers how apoptotic stress can trigger fibroblast growth factor (FGF) signaling, leading to increased expression of anti-apoptotic BCL-2 proteins in neighboring cells. The findings reveal a novel, non-cell autonomous resistance mechanism to apoptosis, with implications for therapeutic strategies targeting BCL-2 in cancer and tissue repair contexts.

• Sulfo-NHS-Biotin: Water-Soluble Protein Labeling Reagent Ins

  2026-05-07

  Sulfo-NHS-Biotin is a highly water-soluble, amine-reactive biotinylation reagent optimized for selective cell surface protein labeling. Its membrane-impermeant chemistry enables precise, irreversible conjugation to accessible primary amines, supporting robust workflows in affinity chromatography and immunoprecipitation. This article details its mechanism, evidence, and limitations for advanced protein analysis.

• S Tag Peptide (A6007): Practical Protocols for Fusion Tag Us

  2026-05-07

  S Tag Peptide enables efficient recombinant protein detection, purification, and solubility enhancement through its charged, antibody-compatible sequence. It should be selected for workflows requiring high aqueous solubility and reliable anti-S-Tag antibody detection, but is not suited for applications needing organic solvent compatibility or independent peptide folding.

• Leveraging ABT-263 (Navitoclax) in Advanced Apoptosis Assays

  2026-05-06

  ABT-263 (Navitoclax) empowers translational cancer research by enabling precision targeting of Bcl-2 family proteins in apoptosis assays. This article distills cutting-edge experimental strategies, troubleshooting insights, and reference-backed parameters to optimize caspase-dependent apoptosis research and model antitumor efficacy in the lab.

16451 records 1/1097 page Next 12345 下5页 Last page